1. Involvement of endometrial IGF-1R/IGF-1/Bcl-2 pathways in experimental polycystic ovary syndrome: Identification of the regulatory effect of melatonin
   Cemile Merve Seymen et al, 2021, Tissue and Cell CrossRef
2. Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation
   F. Guzmán-Mejía et al, 2018, Journal of Neuroimmune Pharmacology CrossRef
3. Melatonin effective to reduce the microscopic symptoms of polycystic ovary syndrome-related infertility: An experimental study
   Gökçe Nur Arık et al, 2023, Tissue and Cell CrossRef
4. Anticancer properties and mechanism of action of the fungal nucleoside clitocine and its derivatives
   Christian Bailly, 2024, European Journal of Medicinal Chemistry Reports CrossRef
5. Cryptotanshinone enhances neurite outgrowth and memory via extracellular signal-regulated kinase 1/2 signaling
   Huiyoung Kwon et al, 2020, Food and Chemical Toxicology CrossRef
6. α-Chaconine and α-Solanine Inhibit RL95-2 Endometrium Cancer Cell Proliferation by Reducing Expression of Akt (Ser473) and ERα (Ser167)
   Ayşe Karaboğa Arslan et al, 2018, Nutrients CrossRef
7. Synthesis and Anticancer Activity of Bagasse Xylan/Resveratrol Graft-Esterified Composite Nanoderivative
   Bin Zhao et al, 2022, Materials CrossRef
8. JNK, p38, ERK, and SGK1 Inhibitors in Cancer
   Jonas Cicenas et al, 2017, Cancers CrossRef
9. GSI Treatment Preserves Protein Synthesis in C2C12 Myotubes
   Joshua R. Huot et al, 2021, Cells CrossRef
10. Immunomolecular evaluation of dihydroartemisinin effects on apoptosis in chronic lymphocytic leukemia cell lines
    Sanem Gökçen et al, 2021, Leukemia Research CrossRef
11. Inhibition of oxidative stress-induced epithelial-mesenchymal transition in retinal pigment epithelial cells of age-related macular degeneration model by suppressing ERK activation
    Ya-Chi Yang et al, 2023, Journal of Advanced Research CrossRef